These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7638745)

  • 1. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions.
    Kang SS; Gosselin C; Ren D; Greisler HP
    Surgery; 1995 Aug; 118(2):280-6; discussion 286-7. PubMed ID: 7638745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue suspensions.
    Shireman PK; Hampton B; Burgess WH; Greisler HP
    J Vasc Surg; 1999 May; 29(5):852-61; discussion 862. PubMed ID: 10231637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin glue containing fibroblast growth factor type 1 and heparin with autologous endothelial cells reduces intimal hyperplasia in a canine carotid artery balloon injury model.
    Zarge JI; Huang P; Husak V; Kim DU; Haudenschild CC; Nord RM; Greisler HP
    J Vasc Surg; 1997 May; 25(5):840-8; discussion 848-9. PubMed ID: 9152311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The S130K fibroblast growth factor-1 mutant induces heparin-independent proliferation and is resistant to thrombin degradation in fibrin glue.
    Shireman PK; Xue L; Maddox E; Burgess WH; Greisler HP
    J Vasc Surg; 2000 Feb; 31(2):382-90. PubMed ID: 10664506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biointeractive polymers and tissue engineered blood vessels.
    Greisler HP; Gosselin C; Ren D; Kang SS; Kim DU
    Biomaterials; 1996 Feb; 17(3):329-36. PubMed ID: 8745330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogenicity and release of vascular endothelial growth factor with and without heparin from fibrin glue.
    Shireman PK; Greisler HP
    J Vasc Surg; 2000 May; 31(5):936-43. PubMed ID: 10805884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor and heparin in a biologic glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibition.
    Weatherford DA; Sackman JE; Reddick TT; Freeman MB; Stevens SL; Goldman MH
    Surgery; 1996 Aug; 120(2):433-9. PubMed ID: 8751615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment.
    Greisler HP; Cziperle DJ; Kim DU; Garfield JD; Petsikas D; Murchan PM; Applegren EO; Drohan W; Burgess WH
    Surgery; 1992 Aug; 112(2):244-54; discussion 254-5. PubMed ID: 1641764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin glue containing fibroblast growth factor type 1 and heparin decreases platelet deposition.
    Zarge JI; Husak V; Huang P; Greisler HP
    Am J Surg; 1997 Aug; 174(2):188-92. PubMed ID: 9293842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R136K fibroblast growth factor-1 mutant induces heparin-independent migration of endothelial cells through fibrin glue.
    Erzurum VZ; Bian JF; Husak VA; Ellinger J; Xue L; Burgess WH; Greisler HP
    J Vasc Surg; 2003 May; 37(5):1075-81. PubMed ID: 12756357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ePTFE coating with fibrin glue, FGF-1, and heparin: effect on retention of seeded endothelial cells.
    Gosselin C; Vorp DA; Warty V; Severyn DA; Dick EK; Borovetz HS; Greisler HP
    J Surg Res; 1996 Feb; 60(2):327-32. PubMed ID: 8598663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
    Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
    Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet deposition on ePTFE grafts coated with fibrin glue with or without FGF-1 and heparin.
    Zarge JI; Gosselin C; Huang P; Vorp DA; Severyn DA; Greisler HP
    J Surg Res; 1997 Jan; 67(1):4-8. PubMed ID: 9070173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
    Xue L; Shireman PK; Hampton B; Burgess WH; Greisler HP
    J Surg Res; 2000 Aug; 92(2):255-60. PubMed ID: 10896831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and biological characterization of an HB-GAM/FGF-1 chimera for vascular tissue engineering.
    Xue L; Tassiopoulos AK; Woloson SK; Stanton DL; Ms CS; Hampton B; Burgess WH; Greisler HP
    J Vasc Surg; 2001 Mar; 33(3):554-60. PubMed ID: 11241127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF-1 affixation stimulates ePTFE endothelialization without intimal hyperplasia.
    Gray JL; Kang SS; Zenni GC; Kim DU; Kim PI; Burgess WH; Drohan W; Winkles JA; Haudenschild CC; Greisler HP
    J Surg Res; 1994 Nov; 57(5):596-612. PubMed ID: 7526046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM).
    Brewster LP; Brey EM; Tassiopoulos AK; Xue L; Maddox E; Armistead D; Burgess WH; Greisler HP
    Am J Surg; 2004 Nov; 188(5):575-9. PubMed ID: 15546573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
    Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
    Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of coacervated alpha-elastin on proliferation of vascular smooth muscle and endothelial cells.
    Ito S; Ishimaru S; Wilson SE
    Angiology; 1998 Apr; 49(4):289-97. PubMed ID: 9555932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin and non-heparin-like dextrans differentially modulate endothelial cell proliferation: in vitro evaluation with soluble and crosslinked polysaccharide matrices.
    Letourneur D; Machy D; Pellé A; Marcon-Bachari E; D'Angelo G; Vogel M; Chaubet F; Michel JB
    J Biomed Mater Res; 2002 Apr; 60(1):94-100. PubMed ID: 11835164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.